Metastatic Colorectal Cancers Completed Phase 1 / 2 Trials for Labetuzumab govitecan (DB12331)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01605318Dose Finding Study of Once or Twice Weekly IMMU-130 in Metastatic Colorectal CancerTreatment